Synlett 2009(4): 648-650  
DOI: 10.1055/s-0028-1087918
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Novel One-Pot, Four-Component Synthesis of 3-Alkyldithiocarbonyl-oxa­zolidines from Aminoethanols, Ketones, Carbon Disulfide, and Halides

Fang-bin Hana,b, Ze-mei Ge*b, Tie-ming Chengb, Run-tao Li*a,b
a State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, P. R. of China
b School of Pharmaceutical Sciences, Peking University, Beijing 100191, P. R. of China
Fax: +86(10)82716956; e-Mail: lirt@mail.bjmu.edu.cn;
Further Information

Publication History

Received 30 September 2008
Publication Date:
16 February 2009 (online)

Abstract

A novel one-pot, four-component synthesis of 3-alkyl­dithiocarbonyloxazolidine derivatives from aminoethanols, ketones, carbon disulfide, and halides was developed. A series of substituted 3-alkyldithiocarbonyloxazolidine derivatives were synthesized in excellent yields utilizing this newly developed method.

    References and Notes

  • 1 Greene TW. Wuts PGM. Protective Groups in Organic Synthesis   3rd ed.:  Wiley-Interscience; New York: 1999.  p.484 
  • 2 Grainger RS. Innocenti P. Angew. Chem. Int. Ed.  2004,  43:  3445 
  • 3 Kanie K. Mizuno K. Kuroboshi M. Hiyama T. Bull. Chem. Soc. Jpn.  1998,  71:  1973 
  • 4a Sugimoto H. Makino I. Hirai K. J. Org. Chem.  1988,  53:  2263 
  • 4b Takikawa Y. Inoue N. Sato R. Takizawa S. Chem. Lett.  1982,  641 
  • 4c Maddani M. Prabhu KR. Tetrahedron Lett.  2007,  48:  7151 
  • 5 Das P. Kumar CK. Kumar KN. Innus Md. Iqbal J. Srinivas N. Tetrahedron Lett.  2008,  49:  992 
  • 6 Wong R. Dolman SJ. J. Org. Chem.  2007,  72:  3969 
  • 7 Guillaneuf Y. Couturier J.-L. Gigmes D. Marque SRA. Tordo P. Bertin D. J. Org. Chem.  2008,  73:  4728 
  • 8 Grainger RS. Welsh EJ. Angew. Chem. Int. Ed.  2007,  46:  5377 
  • 9 Thorn GD. Ludwig RA. The Dithiocarbamates and Related Compounds   Elsevier; Amsterdam: 1962. 
  • 10 Safak C. Erdogan H. Yesilada A. Erol K. Cimgi I. Arzneim. Forsch.  1992,  42:  123 
  • 11a Aboul-Fadl T. El-Shorbagi A. Eur. J. Med. Chem.  1996,  165 
  • 11b Cascio G. Lorenzi L. Caglio D. Manghisi E. Arcamone F. Guanti G. Satta G. Morandotti G. Sperning R. Farmaco  1996,  51:  189 
  • 11c Imamura H. Ohtake N. Jona H. Shimizu A. Moriya M. Sato H. Sugimoto Y. Ikeura C. Kiyonaga H. Nakano M. Hagano R. Abe S. Yamada K. Hashizume T. Morishima H. Bioorg. Med. Chem. Lett.  2001,  9:  1571 
  • 11d Nagano R. Shibata K. Naito T. Fuse A. Asano K. Hashizume T. Nakagawa S. Antimicrob. Agents Chemother.  1997,  41:  2278 
  • 12a Gerhauser C. You M. Liu J. Moriarty RT. Hawthorne M. Mehta RG. Moon RC. Pezzuto JM. Cancer Res.  1997,  57:  272 
  • 12b Scozzafava A. Mastorlorenzo A. Supuran CT. Bioorg. Med. Chem. Lett.  2000,  10:  1887 
  • 12c Ge ZM. Li RT. Cheng TM. Cui JR. Arch. Pharm. Pharm. Med. Chem.  2001,  334:  173 
  • 12d Hou XL. Ge ZM. Wang TM. Guo W. Cui JR. Cheng TM. Lai CS. Li RT. Bioorg. Med. Chem. Lett.  2006,  16:  4214 
  • 13 Gaspari P. Banerjee T. Malachowski WP. Muller AJ. Prendergast GC. DuHadaway J. Bennett S. Donovan AM. J. Med. Chem.  2006,  49:  684 
  • 14a Burke TR. Bajwa BS. Jacobson AE. Rice KC. Streaty RA. Klee WA. J. Med. Chem.  1984,  27:  1570 
  • 14b Walter W. Bode K.-D. Angew. Chem., Int. Ed. Engl.  1967,  6:  281 
  • 15a Lieber E. Orlowski RO. J. Org. Chem.  1957,  22:  88 
  • 15b Lee AWM. Chan WH. Wong HC. Wong MS. Synth. Commun.  1989,  19:  547 
  • 15c Degani I. Fochi R. Synthesis  1978,  365 
  • 16a Salvatore RN. Sahab S. Jung KW. Tetrahedron Lett.  2001,  42:  2055 
  • 16b Nagle AS. Salvatore RN. Cross RM. Kapxhiu EA. Sahab S. Yoon CH. Jung KW. Tetrahedron Lett.  2003,  44:  5695 
  • 17 Tan J. Liang FS. Wang YM. Cheng X. Liu Q. Yuan HJ. Org. Lett.  2008,  10:  2485 
  • 18a Azizi N. Aryanasab F. Saidi MR. Org. Lett.  2006,  8:  5275 
  • 18b Azizi N. Ebrahimi F. Aakbari E. Aryanasab F. Saidi MR. Synlett  2007,  2797 
  • 18c Azizi N. Aryanasab F. Torkiyan L. Ziyaei A. Saidi MR. J. Org. Chem.  2006,  71:  3634 
  • 18d Azizi N. Pourhasan B. Aryanasab F. Saidi MR. Synlett  2007,  1239 
  • 19a Li RT. Ding PY. Han M. Cai MS. Synth. Commun.  1998,  28:  295 
  • 19b Li RT. Cai MS. Synth. Commun.  1999,  29:  65 
  • 19c Ge ZM. Li RT. Cheng TM. Synth. Commun.  1999,  29:  3191 
  • 19d Li RT. Ge ZM. Cheng TM. Cai MS. Chem. J. Chin. Univ.  1999,  20:  1897 
  • 19e Guo BG. Ge ZM. Cheng TM. Li RT. Synth. Commun.  2001,  31:  3021 
  • 19f Cui JL. Ge ZM. Cheng TM. Li RT. Synth. Commun.  2003,  33:  1969 
  • 19g Wang YQ. Ge ZM. Hou XL. Cheng TM. Li RT. Synthesis  2004,  675 
  • 20 Guo BG. Ge ZM. Cheng TM. Li RT. Acta Pharm. Sin.  2001,  36:  185 
  • 22a Villar RM. Gil-Longo J. Daranas AH. Souto ML. Fernández JJ. Peixinho S. Barral MA. Santafé G. Rodríguez J. Jiménez C. Bioorg. Med. Chem.  2003,  11:  2301 
  • 22b Hirai G. Oguri H. Hayashi M. Koyama K. Koizumi Y. Moharram SM. Hirama M. Bioorg. Med. Chem. Lett.  2004,  14:  2647. 
  • 22c Bruncko M. Oost TK. Belli BA. Ding H. Joseph MK. Kunzer A. Martineau D. McClellan WJ. Mitten M. Ng S.-C. Nimmer PM. Oltersdorf T. Park C.-M. Petros AM. Shoemaker AR. Song X. Wang X. Wendt MD. Zhang H. Fesik SW. Rosenberg SH. Elmore SW. J. Med. Chem.  2007,  50:  641 
  • 23 Sebti S. Zahouily M. Lazrek HB. Mayoral JA. Macquarrie DJ. Curr. Org. Chem.  2008,  12:  203 
21

Li, R. T. unpublished results.

24

Typical Procedure for the Synthesis of Compounds 3
To a solution of aminoethanol (2 mmol) in acetone (10 mL) was added anhyd K3PO4 (4 mmol), and the reaction mixture was stirred at r.t. for 30 min. CS2 (4 mmol) was then added dropwise. The reaction mixture was stirred for an additional 20 min, and halide (2 mmol) was then added. Stirring was continued at r.t. until the reaction was completed (monitored by TLC). The precipitate was filtered and washed with acetone. The solvent was evaporated under reduced pressure, and the residue was purified by chromatography on a silica gel column (PE-EtOAc) to give the desired compounds 3.
Selected Data for Compound 3f
White solid; mp 104-106 ˚C. ¹H NMR (300 MHz, CDCl3): δ = 1.83 (s, 6 H), 2.81 (t, J = 7.8 Hz, 2 H), 3.30 (t, J = 8.1 Hz, 2 H), 3.82 (t, J = 6.3 Hz, 2 H), 4.06 (t, J = 6.3 Hz, 2 H), 7.26-7.49 (m, 10 H). MS (EI, 70 eV): m/z (%) = 396 (6) [M]+, 204 (7), 193 (7), 177 (55), 165 (15), 144 (57), 118 (25), 86 (100). Anal. Calcd for C23H26N2OS2: C, 66.63; H, 6.10; N, 7.06. Found: C, 66.71; H, 6.10; N, 7.03.
Selected Data for Compound 3h Light yellow oil. ¹H NMR (300 MHz, CDCl3): δ = 1.30 (t, J = 7.2 Hz, 3 H), 1.83 (s, 6 H), 3.93 (t, J = 6.3 Hz, 2 H), 4.10 (t, J = 6.3 Hz, 2 H), 4.13 (s 2 H), 4.23 (q, J = 7.2 Hz, 2 H). Anal. Calcd for C10H17NO3S2: C, 45.60; H, 6.51; N, 5.32. Found: C, 45.45; H, 6.57; N, 5.36.